Viridian Therapeutics, Inc.\DE (VRDN) Gross Profit (2013 - 2016)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Gross Profit came in at -$183000.0 in Q4 2016, down 190.15% year-on-year from $203000.0 in Q1 2016, and down 154.3% quarter-over-quarter from $337000.0 in Q3 2016.
Viridian Therapeutics, Inc.\DE (VRDN) Gross Profit (2013 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Gross Profit history runs 4 years deep, the most recent figure standing at -$183000.0 for Q4 2016.
- On a quarterly basis, Gross Profit fell 190.15% year-over-year to -$183000.0 in Q4 2016; TTM through Dec 2016 was $929000.0, a 2.99% increase from a year earlier, with the FY2016 full-year figure at -$1.9 million, down 2956.06% from the prior year.
- Gross Profit declined to -$183000.0 in Q4 2016 per VRDN's latest filing, from $337000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $972000.0 in Q3 2014 and bottomed at -$183000.0 in Q4 2016.
- The 4-year median for Gross Profit is $348500.0 (2014), against an average of $361649.1.
- Biggest YoY gain for Gross Profit was 769.64% in 2016; the steepest drop was 190.15% in 2016.
- Year by year, Gross Profit stood at $723157.0 in 2013, then slumped by 117.42% to -$126000.0 in 2014, then soared by 261.11% to $203000.0 in 2015, then plunged by 190.15% to -$183000.0 in 2016.
- Per Business Quant, the three latest VRDN Gross Profit figures stand at -$183000.0 (Q4 2016), $337000.0 (Q3 2016), and $487000.0 (Q2 2016).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -183,000.00 |
| Dec 31, 2016 | -183,000.00 |
| Sep 30, 2016 | 337,000.00 |
| Sep 30, 2016 | 337,000.00 |
| Jun 30, 2016 | 487,000.00 |
| Jun 30, 2016 | 487,000.00 |
| Mar 31, 2016 | 288,000.00 |
| Mar 31, 2016 | 288,000.00 |
| Dec 31, 2015 | 203,000.00 |
| Dec 31, 2015 | 203,000.00 |
| Sep 30, 2015 | 758,000.00 |
| Sep 30, 2015 | 758,000.00 |
| Jun 30, 2015 | 56,000.00 |
| Jun 30, 2015 | 56,000.00 |
| Mar 31, 2015 | -115,000.00 |
| Mar 31, 2015 | -115,000.00 |
| Dec 31, 2014 | -126,000.00 |
| Dec 31, 2014 | -126,000.00 |
| Sep 30, 2014 | 972,000.00 |
| Sep 30, 2014 | 972,000.00 |